[1] |
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1):7-30.
|
[2] |
Sanchez-Muñoz A, Pérez-Ruiz E, Jurado JM, et al. Outcome of small invasive breast cancer with no axillary lymph node involvement[J]. Breast J, 2011, 17 (1):32-38.
|
[3] |
Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al. Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma[J]. J Clin Oncol, 2007, 25(31):4952-4960.
|
[4] |
Riedl CC, Luft N, Bernhart C, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density[J]. J Clin Oncol, 2015, 33(10): 1128-1135.
|
[5] |
Meissnitzer M, Dershaw DD, Feigin K, et al. MRI appearance of invasive subcentimeter breast carcinoma: benign characteristics are common[J]. Br J Radiol, 2017, 90(1074):20 170 102.
|
[6] |
Raza S, Sekar M, Ong EM, et al. Small masses on breast MR: is biopsy necessary? [J]. Acad Radiol, 2012, 19(4):412-419.
|
[7] |
Gibbs P, Liney GP, Lowry M, et al. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI [J]. Breast, 2004,13(2):115-121.
|
[8] |
Dietzel M, Baltzer PA, Vag T, et al. Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging? [J]. J Comput Assist Tomogr, 2010, 34(3):456-464.
|
[9] |
Ha R, Sung J, Lee C, et al. Characteristics and outcome of enhancing foci followed on breast MRI with management implications[J]. Clin Radiol, 2014, 69(7): 715-720.
|
[10] |
Spick C, Pinker-Domenig K, Rudas M, et al. MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies[J]. Eur Radiol, 2014, 24(6):1204-1210.
|
[11] |
Arponen O, Masarwah A, Sutela A, et al. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity[J]. Eur Radiol, 2016, 26(12):4361-4370.
|
[12] |
Zhu W, Harvey S, Macura KJ, et al. Invasive breast cancer preferably and predominantly occurs at the interface between fibroglandular and adipose tissue[J]. Clin Breast Cancer, 2017,17 (1): e11-e18.
|
[13] |
Clauser P, Marcon M, Maieron M, et al. Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study[J]. Eur Radiol, 2016, 26(7):2291-2296.
|
[14] |
Morris EA, Comstock CE, Lee CH, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System [M]. Reston: American College of Radiology, 2013:1-173[2019-12-14].
|
[15] |
Tominaga J, Hama H, Kimura N, et al. Magnetic resonance imaging of intraductal papillomas of the breast[J]. J Comput Assist Tomogr, 2011, 35(1): 153-157.
|
[16] |
李艳翠,梁雯,彭峰河,等. 乳腺硬化性腺病的影像表现及病理分析[J]. 磁共振成像,2018, 9:133-148.
|
[17] |
Cohen MA, Newell MS. Radial scars of the breast encountered at core biopsy: Review of histologic, imaging, and management considerations[J]. AJR Am J Roentgenol, 2017, 209(5):1168-1177.
|
[18] |
Kurz KD, Roy S, Saleh A, et al. MRI features of intraductal papilloma of the breast: sheep in wolf’s clothing? [J]. Acta Radiol, 2011, 52(3):264-272.
|
[19] |
Zhu Y, Zhang S, Liu P, et al. Solitary intraductal papillomas of the breast: MRI features and differentiation from small invasive ductal carcinomas[J]. AJR Am J Roentgenol, 2012, 199(4): 936-942.
|
[20] |
Kawashima H, Kobayashi-Yoshida M, Matsui O, et al. Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings[J]. J Magn Reson Imaging, 2010,32(5):1117-1123.
|
[21] |
Westra C, Dialani V, Mehta TS, et al. Using T2-weighted sequences to more accurately characterize breast masses seen on MRI[J]. AJR Am J Roentgenol, 2014, 202(3): 183-190.
|
[22] |
Wan CW, Lee CY, Lui CY, et al. Apparent diffusion coefficient in differentiation between malignant and benign breast masses: does size matter? [J]. Clin Radiol, 2016, 71(2):170-177.
|